RetractedArticleRSC advances2020

Novel fatty chain-modified GLP-1R G-protein biased agonist exerts prolonged anti-diabetic effects through targeting receptor binding sites.

Maorong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.